Viimeisimmät kokeilut

EudraCT Number: 2005-001055-38

Sponsor Protocol Number: IELSG20

Start Date: 2003-11-28

Sponsor Name: INTERNATIONAL EXTRANODAL LYMPHOMA STUDY GROUP IELSG

Full Title: RANDOMIZED PHASE II TRIAL ON PRIMARY CHEMOTHERAPY WITH HIGH-DOSE METHOTREXATE, ALONE OR ASSOCIATED WITH HIGHDOSE CYTARABINE, FOLLOWED BY RESPONSE- AND AGE-TAILORED RADIOTHERAPY FOR IMMUNOCOMPETENT ...

Medical condition: primary chemotherapy of primary central nervous system lymphoma with high dose cytarabine plus methotrexate

Disease:	Version	SOC Term	Classification Code	Term	Level
	6.1		10012818		PT

Population Age: Adults

Gender: Male, Female

Trial protocol: IT (Completed)

Trial results: (No results available)

EudraCT Number: 2004-002113-36

Sponsor Protocol Number: EORTC 62012

Start Date: 2003-05-20

Sponsor Name: European Organisation for the Research and Treatment of Cancer

Full Title: Randomised trial of single agent doxorubicin versus doxorubicin plus ifosfamide in the first line treatment of advanced or metastatic soft tissue sarcoma

Medical condition: Locally advanced or metastatic soft tissue sarcoma

Disease:	Version	SOC Term	Classification Code	Term	Level
	8.1		10041299		HLGT

Population Age: Adults

Gender: Male, Female

Trial protocol: SK (Completed)

Trial results: View results

EudraCT Number: 2006-003746-42

Sponsor Protocol Number: om 145

Start Date: 2003-02-11

Sponsor Name: OSPEDALE ONCOLOGICO DI BARI

Full Title: Immunotherapy vs immuno-chemotherapy in patients with metastatic kidney carcinoma

Medical condition: metastatic kidney carcinoma

Disease:	Version	SOC Term	Classification Code	Term	Level
	6.1		10038408		HLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: IT (Ongoing)

Trial results: (No results available)

EudraCT Number: 2006-002737-21

Sponsor Protocol Number: om 2002

Start Date: 2002-09-10

Sponsor Name: OSPEDALE ONCOLOGICO DI BARI

Full Title: A randomized phase II study in the advanced or metastatic transitional cell urotelium carcinoma between Gemcitabine + Cisplatin e Gemcitabine + Cisplatino + Taxolo

Medical condition: Advanced transitional cell bladder carcinoma

Disease:	Version	SOC Term	Classification Code	Term	Level
	9.1		10029104	Neoplasms benign, malignant and unspecified (incl cysts and polyps)	SOC

Population Age: Adults

Gender: Male, Female

Trial protocol: IT (Ongoing)

Trial results: (No results available)

EudraCT Number: 2006-002053-69

Sponsor Protocol Number: 3068A1-301-WW

Start Date: 2002-08-13

Sponsor Name: Wyeth Research Division of Wyeth Pharmaceuticals Inc.

Full Title: FRACTURE INCIDENCE REDUCTION AND SAFETY OF TSE-424 (BAZEDOXIFENE ACETATE) COMPARED TO PLACEBO AND RALOXIFENE IN OSTEOPOROTIC POSTMENOPAUSAL WOMEN

Medical condition: Reduction of new vertebral fractures in osteoporotic postmenopausal women- Osteoporosis

Disease:	Version	SOC Term	Classification Code	Term	Level
	9.1		10031282	Osteoporosis	LLT

Population Age: Adults, Elderly

Gender: Female

Trial protocol: HU (Completed) BG (Completed)

Trial results: View results

EudraCT Number: 2006-004084-66

Sponsor Protocol Number: om 112

Start Date: 2002-07-09

Sponsor Name: OSPEDALE ONCOLOGICO DI BARI

Full Title: A phase II study on the efficacy and safety of topotecan in the treatment of patients with brain metastases

Medical condition: Brain metastases

Disease:	Version	SOC Term	Classification Code	Term	Level
	6.1		10061287		PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: IT (Ongoing)

Trial results: (No results available)

EudraCT Number: 2005-002385-11

Sponsor Protocol Number: BIG01−01/BO16348B

Start Date: 2002-05-16

Sponsor Name: F. HOFFMANN - LA ROCHE LTD.

Full Title: -

Medical condition: -

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.0	100000004864	10006173	Breast adenocarcinoma	LLT

Population Age: Adults, Elderly

Gender: Female

Trial protocol: IT (Completed)

Trial results: (No results available)

EudraCT Number: 2008-005127-29

Sponsor Protocol Number: TAX_GMA_302

Start Date: 2001-05-21

Sponsor Name: SANOFI-AVENTIS

Full Title: MULTICENTER PHASE III RANDOMIZED TRIAL COMPARING DOXORUBICIN AND CYCLOPHOSPHAMIDE FOLLOWED BY DOCETAXEL (AC->T) WITH DOXORUBICIN AND CYCLOPHOSPHAMIDE FOLLOWED BY DOCETAXEL AND TRASTUZUMAB (HERCEPTI...

Medical condition: node positive and high risk node negative patients with operable breast cancer containing the the HER2 alteration.

Disease:	Version	SOC Term	Classification Code	Term	Level
	9.1		10057654	Breast cancer female	LLT

Population Age: Adults, Elderly

Gender: Female

Trial protocol: HU (Completed) SK (Completed)

Trial results: View results

EudraCT Number: 2004-000238-36

Sponsor Protocol Number: IST-399

Start Date: 1999-10-05

Sponsor Name: The University of Edinburgh & Lothian Health Board

Full Title: Third International Stroke Trial (IST-3) of thrombolysis for acute ischaemic stroke

Medical condition: Acute ischaemic stroke refers to strokes caused by thrombosis or embolism and accounts for 85% of all strokes.

Disease:	Version	SOC Term	Classification Code	Term	Level
	9.1		10023027	Ischaemic stroke NOS	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (Completed) PT (Completed)

Trial results: View results

EudraCT Number: 2009-018118-21

Sponsor Protocol Number: OXN2503

Start Date:

Sponsor Name: Mundipharma Research GmbH & Co. KG

Full Title: An exploratory, randomised, double-blind, placebo-controlled, parallel group, pilot study to assess the analgesic efficacy of oxycodone/naloxone prolonged release tablets (OXN PR) compared to place...

Medical condition: Bladder Pain Syndrome (BPS), formerly addressed as IC/PBS (interstitial cystitis /Painful Bladder Syndrome)

Disease:	Version	SOC Term	Classification Code	Term	Level
	14.1	100000004857	10008927	Chronic interstitial cystitis	LLT

Population Age: Adults, Elderly

Gender: Female

Trial protocol: DE (Completed) HU (Completed) CZ (Completed) GB (Completed)

Trial results: View results

Viimeisimmät kokeilut

Sponsorit ja yhteistyökumppanit

Sairaudet

Huumeiden interventiot